Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93760781 | 9376078 | 1 | I | 2013 | 20130619 | 20130630 | 20130630 | PER | US-009507513-1306USA010819 | MERCK | 0.00 | F | Y | 0.00000 | 20130630 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93760781 | 9376078 | 1 | PS | VICTRELIS | 1 | ORAL | 800 MG, TID | D | 2HCE021 | 202258 | 800 | MG | CAPSULE | TID | |||||
| 93760781 | 9376078 | 2 | SS | RIBAPAK | 1 | UNK | D | 0 | |||||||||||
| 93760781 | 9376078 | 3 | SS | PEGASYS | 1 | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93760781 | 9376078 | 1 | Hepatitis C |
| 93760781 | 9376078 | 2 | Hepatitis C |
| 93760781 | 9376078 | 3 | Hepatitis C |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93760781 | 9376078 | Viral load increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93760781 | 9376078 | 1 | 20130307 | 2013 | 0 |